ducovest

MDYV:ARCA-SPDR S&P 400 Mid Cap Value ETF (based on S&P MidCap 400 Value Index--symbol: MGD (USD)

ETF | Mid-Cap Value | NYSE Arca

Last Closing

USD 82.23

Change

-0.47 (-0.57)%

Market Cap

USD 0.33B

Volume

0.14M

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

The investment seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of the S&P MidCap 400 Value Index. The fund generally invests substantially all, but at least 80%, of its total assets in the securities comprising the index. The index measures the performance of the mid-capitalization value segment of the U.S. equity market. It may purchase a subset of the securities in the index in an effort to hold a portfolio of securities with generally the same risk and return characteristics of the index. The fund is non-diversified.

Company Website : www.spdrs.com

Currency: USD

Country : USA

Inception Date: 08/11/2005

Primary Benchmark: S&P MidCap 400 Value TR USD

Primary Index: S&P 500 TR USD

Gross Expense Ratio: 0.15%

Management Expense Ratio: 0.15 %

Unadjusted Closing Price

Adjusted Closing Price

Assets

N/A

Top Holdings

N/A

Symbol Company Name Allocation
TARS Tarsus Pharmaceuticals Inc 1.07 %
Top Sectors

N/A

Top Regions

N/A

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-02-20 )

Largest Industry Peers for Mid-Cap Value

Symbol Name Mer Price(Change) Market Cap
VOE Vanguard Mid-Cap Value Index F.. 0.07 %

-1.85 (-1.11%)

 USD 17.76B
IWS iShares Russell Mid-Cap Value .. 0.24 %

-2.30 (-1.73%)

 USD 13.74B
IJJ iShares S&P Mid-Cap 400 Value .. 0.25 %

-2.22 (-1.74%)

 USD 8.59B
KOMP SPDR Kensho New Economies Comp.. 0.00 %

-1.58 (-2.95%)

 USD 2.20B
PVAL Putnam Focused Large Cap Value.. 0.29 %

-0.75 (-1.90%)

 USD 2.01B
IVOV Vanguard S&P Mid-Cap 400 Value.. 0.20 %

-1.83 (-1.87%)

 USD 0.94B
XMLV Invesco S&P MidCap Low Volatil.. 0.25 %

-0.39 (-0.64%)

 USD 0.77B
DIV Global X SuperDividend U.S. ET.. 0.46 %

-0.07 (-0.37%)

 USD 0.64B
VUSE Vident Core U.S. Equity Fund 0.51 %

-1.18 (-1.91%)

 USD 0.61B
XMVM Invesco S&P MidCap Value with .. 0.39 %

-1.19 (-2.10%)

 USD 0.27B

ETFs Containing MDYV

N/A

Market Performance

  Market Performance vs. Industry/Classification (Mid-Cap Value) Market Performance vs. Exchange (NYSE Arca)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 2.53% 40% F 51% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 2.53% 40% F 50% F
Trailing 12 Months  
Capital Gain 14.02% 64% D 68% D+
Dividend Return 1.44% 43% F 25% F
Total Return 15.45% 43% F 65% D
Trailing 5 Years  
Capital Gain 51.27% 63% D 72% C
Dividend Return 10.33% 63% D 32% F
Total Return 61.60% 56% F 71% C-
Average Annual (5 Year Horizon)  
Capital Gain 13.95% 69% C- 73% C
Dividend Return 15.20% 56% F 71% C-
Total Return 1.26% 56% F 30% F
Risk Return Profile  
Volatility (Standard Deviation) 26.54% 38% F 41% F
Risk Adjusted Return 57.29% 44% F 70% C-
Market Capitalization 0.33B N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.